IP Library › Granted Patent US 7,595,395
Granted Patent B2
US 7,595,395 · App. 11/383,624 · Granted Sep 29, 2009

Gabaergic agents to treat memory deficits

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,595,395
App. No.
11/383,624
Granted
Sep 29, 2009
Kind
B2
Abstract

The present invention provides molecules and methods for the prevention and/or treatment of memory deficit related conditions and/or enhancement of cognizance. In a preferred embodiment, the invention includes compounds, salts and prodrugs thereof for the prevention and/or treatment of these conditions.

Claims (2)

1. A compound selected from the group consisting of:

and a pharmaceutically acceptable salt thereof.

Assignments (4)
CONFIRMATORY LICENSE Recorded Mar 4, 2010
From: WISYS TECHNOLOGY FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024026/0103 →
CONFIRMATORY LICENSE Recorded Mar 4, 2010
From: WISYS TECHNOLOGY FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024026/0207 →
SECURITY AGREEMENT Recorded Sep 30, 2009
From: THE YANKEE CANDLE COMPANY, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 023304/0067 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2006
From: COOK, JAMES M.; CLAYTON, TERRY; HAN, DONGMEI
To: WISYS TECHNOLOGY FOUNDATION
Reel/Frame 017926/0301 →